VVOS fundamentals
An in-depth look to Vivos Therapeutics, Inc. operating, investing, and financing activities
VVOS free cash flow for Q3 24 is -4.38 M USD. For 2023, VVOS free cash flow was -12.75 M USD and operating cash flow was -11.95 M USD.
Q3 '19
Q4 '19
Q1 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: USD
Q3 '19
Q4 '19
Q1 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
TTM